1. Tumor-Induced Hypoglycemia: An Unusual Case Report and Review of Literature
- Author
-
Patamaporn Lekprasert, Basma Abdulhadi, and Catherine Anastasopoulou
- Subjects
Poor prognosis ,endocrine system ,endocrine system diseases ,030209 endocrinology & metabolism ,Case Report ,Low insulin ,Hypoglycemia ,Bioinformatics ,Diseases of the endocrine glands. Clinical endocrinology ,Pheochromocytoma ,03 medical and health sciences ,0302 clinical medicine ,Rare case ,medicine ,Unusual case ,biology ,business.industry ,nutritional and metabolic diseases ,General Medicine ,medicine.disease ,RC648-665 ,pheochromocytoma ,Work-up ,hypoglycemia ,IGF-2, insulin-like growth factor 2 ,TIH, tumor-induced hypoglycemia ,030220 oncology & carcinogenesis ,Insulin-like growth factor 2 ,biology.protein ,business ,tumor-induced hypoglycemia - Abstract
Objective To describe a rare case of pheochromocytoma presenting with hypoglycemia. Methods We describe a rare case of pheochromocytoma presenting with a hypoglycemic seizure. Our article includes our differentials, work up, and management. Results Our patient had non–islet-cell tumor hypoglycemia that was non-insulin mediated, as noted by low insulin levels. His hypoglycemia was likely multifactorial and mediated by different mechanisms. We describe the rare case and review the causes of tumor-induced hypoglycemia. Conclusion Pheochromocytomas can rarely present with hypoglycemia and are associated with a poor prognosis.
- Published
- 2021